Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Irbesartan/Hydrochlorothiazide Combination: A Comparison of Active and Usual Titration Regimen in the Treatment of Hypertensive Patients Insufficiently Controlled by Monotherapy

NCT00708344 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT00708344
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00708344 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Irbesartan/Hydrochlorothiazide Combination: A Comparison of Active and Usual Titration Regimen in the Treatment of Hypertensive Patients Insufficiently Controlled by Monotherapy
Lead sponsor
Sanofi
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2008
Completion date
July 31, 2009
Enrollment
832 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension